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Abstract
Invasive and noninvasive monitoring facilitates clinical evaluation
when resuscitating patients with complex haemodynamic disorders.
If the macrocirculation is to be stable, then it must adapt to blood
flow or blood flow must be optimized. The objective of flow
monitoring is to assist with matching observed oxygen consump-
tion (VO2) to pathophysiological needs. If an adequate balance
cannot be maintained then dysoxia occurs. In this review we
propose a simple schema for global reasoning; we discuss the
limitations of VO2 and arterial oxygen delivery (DaO2) assessment;
and we address concerns about increasing DaO2 to supranormal
values or targeting pre-established levels of DaO2, cardiac output,
or mixed venous oxygen saturation. All of these haemodynamic
variables are interrelated and limited by physiological and/or
pathological processes. A unique global challenge, and one that is
of great prognostic interest, is to achieve rapid matching between
observed and needed VO2 – no more and no less. However,
measuring or calculating these two variables at the bedside
remains difficult. In practice, we propose a distinction between
three situations. Clinical and blood lactate clearance improvements
can limit investigations in simple cases. Intermediate cases may be
managed by continuous monitoring of VO2-related variables such
as DaO2, cardiac output, or mixed venous oxygen saturation. In
more complex cases, three methods can help to estimate the
needed VO2 level: comparison with expected values from past
physiological studies; analysis of the relationship between VO2 and
oxygen delivery; and use of computer software to integrate the
preceding two methods.
Introduction
Major advances have been made in monitoring the critically ill
patient following the introduction in the 1970s of intra-
vascular pressure and flow recording catheters [1]. Today,
flow monitoring is one of the major reasons to admit patients
into an intensive care unit (ICU), but which of the flow-based
parameters are really interesting from a clinical perspective?
A reasonable assumption is that below a critical level the
oxygen consumption (VO2) is inversely related to the risk for
cell dysfunction and necrosis and to the severity of shock.
Among the various haemodynamic variables that may be
evaluated, a VO2 below the required level is most strongly
related to death [2]. Once a substantial amount of cell
necrosis has occurred, organ function recovery is not always
possible, even when adequate VO2 is restored. Thus, it is
intuitive that flow monitoring must be aimed at early
adaptation of VO2 to metabolic needs [3,4]. Although this is
universally accepted, its usefulness at the bedside has been
challenged because of theoretical and practical limitations of
VO2 assessment [5,6]. However, it has been shown that
several of these limitations have been over-stated [4]. In
addition, targeting a VO2 that is adequate to meet the
patient’s needs does not necessarily require continuous VO2
measurement. Monitoring VO2-related variables such as
cardiac output (CO) and/or mixed venous oxygen saturation
(SvO2) may represent an acceptable compromise, especially
as these variables can be obtained less invasively.
This review proposes a simple and comprehensive schema
for understanding and adapting flow monitoring in order to
stabilize the macrocirculation.
Fundamental basis of the relationship
between oxygen consumption and delivery
For each cell, life requires enough energy for metabolic
activity. Energy depends on oxidative reactions that require
nutrients and oxygen. For each cell most of the oxygen is
used for oxidative mechanisms. Nonoxidative systems have
lower affinity for oxygen than do cytochrome oxidase systems.
Therefore, significant activity of the non-mitochondrial oxidase
systems can only be present when there is no more dysoxia.
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Hence, for each cell a match between VO2 and needed VO2
(nVO2) is necessary for life. This basic relationship between
life and energy is also applicable to each organ and to the
body as a whole. However, a whole body VO2 that equals
body needs does not guarantee that circulation is adequate
for each cell because distributive mismatch may lead to
nonoxidative metabolism in some areas and dysoxia in others.
However, it is a prerequisite that the macrocirculation must
be stabilized before one may examine the microcirculation.
Consequently, the first priority is to consider the balance
between whole body VO2 and nVO2.
For all systems, VO2 is the difference between the input flow
and the output flow. For the whole body circulation, the input
flow is the arterial oxygen delivery (DaO2) and the output flow
is the venous oxygen delivery. If one considers the oxygen
extraction ratio (EO2) to be the ratio between VO2 and DaO2,
then VO2 can be represented by the product DaO2 × EO2. The
simple equation VO2 = DaO2 × EO2 is conventionally used to
represent the macrocirculatory balance.
The VO2 observed (oVO2) by a clinician (either measured or
calculated) is the product of an observed DO2 and an
observed EO2, such that oVO2 = oDO2 × oEO2. Similarly, the
specific patient’s requirements (nVO2) may be formulated as
the product of the needed DO2 and the needed EO2: nVO2 =
nDO2 × nEO2. The ratio between these two equations repre-
sents the balance between what the doctor sees and what
the patient needs: oVO2/nVO2 = oDO2/nDO2 × oEO2/nEO2. Any
change in oDO2/nDO2 must be balanced by an inverse change
in oEO2/nEO2 to maintain oVO2/nVO2 = 1 and vice versa. When
oVO2/nVO2 = 1 cannot be maintained, dysoxia occurs.
Consequently, three indices of performance may be
described: oVO2/nVO2 is an index of global performance, with
a value below 1 indicating shock; oDO2/nDO2 is an index of
circulatory performance, with a value below 1 indicating
circulatory failure; and oEO2/nEO2 is an index of tissue
performance, with a value below 1 indicating tissue failure.
We do not propose that these indices be calculated for each
and every patient, but they should perhaps be borne in mind
to facilitate, at any time, empirical review of the patient’s likely
status and to determine the probable results of any
therapeutic intervention.
Clinical means to deal with concepts
Evaluation of whether macrocirculatory adaptation is
adequate requires one to answer several simple questions.
Is oxygen consumption equal to the patient’s needs?
Otherwise stated, is the expression oVO2/nVO2 = 1 true?
Three levels of complexity may be defined.
First, clinical improvement is a good indicator of adequate
resuscitation [7]. In practice, the nVO2 is usually met by
decreasing metabolic requirement, optimizing the haematocrit
and arterial haemoglobin oxygen saturation, and increasing
blood flow empirically until the clinical status improves. This
situation does not require invasive haemodynamic
investigation.
Second, a clear improvement in blood lactate clearance is
also a good and minimally invasive indicator of adequate
resuscitation [7]. The blood lactate concentration alone fails
to discriminate between dysoxia and aerobiosis [8]. Although
more reliable, the time course of lactate levels is not an ideal
marker [2,7,9]. The limitations of lactate were recently
reviewed [8]. Diabetes mellitus, liver dysfunction, tissue
reperfusion, catecholamine infusion, cellular metabolic altera-
tions and inhibition of pyruvate dehydrogenase can all result
in a marked increase in blood lactate concentrations, despite
improvement in tissue dysoxia.
Finally, in more complex situations in which clear clinical
improvement and normalization in blood lactate are not
observed, evaluation of oxygenation is required, followed by
an evaluation of oVO2 and nVO2. The oVO2 can be measured at
the bedside using expired gases [10] or it may be calculated
from the product of CO and the arteriovenous difference in
blood oxygen content. Demonstrating that oVO2/nVO2 = 1
requires one to evaluate nVO2 concomitantly. When oVO2 is
evaluated alone, this provides no information of prognostic
interest [2].
How may we estimate the needed oxygen consumption?
Needs can initially be estimated as the sum of VO2 at basal
metabolism, as indicated by age-specific and sex-specific
normative data, and the additional VO2 that results from other
metabolic requirements. The latter can be approximated
based on a number of factors, such as body temperature
(nVO2 changes by ±13% for each 1°C above or below
37°C). Pathologic situations such as respiratory failure and
severe sepsis also increase metabolic needs. Based on
metabolic conditions, nVO2 can vary from 0.7-fold to 3-fold
the basal metabolism.
Needs can also be estimated by using the specific VO2/DO2
relationship (Figure 1). A biphasic relationship between oxygen
use and resources has been established [6]. When DO2 is
greater than a threshold value, VO2 remains stable (oxygen
supply independency) because the EO2 changes propor-
tionally. When DO2 falls below this threshold, a proportionate
increase in EO2 cannot be maintained and the VO2 drops
linearly to zero (oxygen supply dependency). There is consen-
sus that the inflection point between the two slopes indicates
the critical level of DO2 (Figure 1). Oxygen supply depen-
dency is associated with increased blood lactate concentra-
tion, denoting possible activation of the anaerobic pathway.
Assessment of the VO2/DO2 relationship is a theoretical means
to evaluate the gap between actual VO2 and nVO2. When DO2
increases, an increase in VO2 suggests that oxygen supply isPage 3 of 7
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inadequate. In contrast, a stable VO2 value when DO2
increases suggests either that VO2 matches needs when it is
associated with decreasing lactate levels [11,12] or that VO2
is limited by mechanisms other than oxygen supply when it is
associated with increasing lactate levels [13,14].
In pathophysiology, two mechanisms delay achievement of the
VO2 plateau and account for a rightward shift in the critical DO2
point (Figure 1). When VO2 needs are excessive (uncoupling
and/or increased metabolic activity), the VO2 plateau is reached
at a higher level of VO2 [15,16]. When oxygen tissue diffusion
is impaired (impaired microcirculation and/or impaired oxygen
mitochondrial use), the slope of the dependant part of the
VO2/DO2 relationship is decreased [17,18].
Three other mechanisms result in an increase in VO2 as DO2
increases beyond the critical point, so that a slight upward
slope – usually of less than 5% – replaces the expected VO2
plateau. Although more difficult, identification of the critical
DO2 inflection point remains possible when these mecha-
nisms are operative because the slope of the VO2/DO2
dependency segment ranges from 20% to 50% [19]. The
first mechanism occurs during a DO2 challenge involving an
increase in CO, because the VO2 needs of kidneys [20],
stomach [21] and muscle [22] increase in direct proportion
to flow. Furthermore, infusion of inotropic agents increases
myocardial oxygen consumption [11,12,19]. Another mecha-
nism is additional oxygen uptake due to non-mitochondrial
oxidase systems when dysoxia has resolved [23]. The final
mechanism, termed conformance, is a decrease in the
metabolic needs of cells that occurs in response to a gradual
decline in available oxygen. Although secondary to a chronic
change, this phenomenon has been observed in acute
situations [24]. Schumacker and coworkers [25] reported
that a VO2 increase occurred in unshocked patients after
aortic stenosis valvuloplasty.
A controversy arose during the late 1980s from several
studies on acute respiratory distress syndrome and/or sepsis,
in which the expected VO2 plateau was not observed in
patients who were recovering from shock and had high DO2
values [26,27]. This was interpreted as evidence of
‘pathologic oxygen supply dependency’, possibly related to
hidden oxygen deficit and contributing to multiorgan failure
and death. However, increasing DO2 to supranormal values
was beneficial in some studies [28,29] but not in others
[30,31]. Furthermore, it has been suggested this so-called
‘pathologic supply dependency’ may result from spurious up-
sloping of the VO2/DO2 relationship due to mathematical
coupling of measurement errors when using a pulmonary
artery catheter (PAC), because in some studies simultaneous
independent VO2 assessment revealed a plateau [5,6,32]. In
addition, VO2 and DO2 assessment are limited by theoretical
and practical concerns [5,6]. However, these limitations were
recently reviewed [4]. Use of the most recent generation of
devices for continuous CO monitoring and blood gas analysis
minimizes the variability in measurement. It has been
proposed that the relevance of the VO2/DO2 relationship
could be increased by combined analysis of the VO2/time
relationship (Figure 2) [4]. Thus, although difficult, acceptable
identification of the VO2 plateau, and of the nVO2, is possible
when necessary.
Finally, it may be concluded that oVO2 = nVO2 when one or
several of the following factors is present: clinical improve-
ment, decrease in blood lactate concentration, and oVO2
inside the expected range and/or inflexion point in the
oVO2/DO2 curve. The two methods can be combined. When
the oVO2 plateau is reached at a value close to the estimated
needs, the patient’s real needs are probably met. Handling
the large amount of information required to assess oxygen
needs can be difficult [33,34], and computer assistance may
be helpful [2,35,36].
Are there other means to balance oxygen
consumption and needs?
Supraphysiologic targets
Some investigators have recommended that DO2 be
increased to supranormal values, greater than the usual
critical level, without paying much attention to VO2. This
simplification of the method based on the VO2/DO2 relation-
ship was associated with favourable outcomes in homoge-
neous populations of patients undergoing high-risk surgery
[37,38], with cardiogenic shock following myocardial infarc-
tion [39] and with acute respiratory failure [15,40]. However,
those studies failed to demonstrate any beneficial effects
after the onset of organ failure [38] or when different aetio-
logies of shock were pooled together [15,40].
Available online http://ccforum.com/content/10/S3/S4
Figure 1
Pathophysiological changes in the VO2/DO2 relationship. Normal
relationship is shown in a solid black line, and abnormal relationships in
dotted lines. 1: Increased VO2 needs; 2: impaired EO2; 3: other
mechanisms (see text). The grey curves are the corresponding
EO2/DO2 relationships. DO2, oxygen delivery; EO2, oxygen extraction
ratio; VO2, oxygen consumption. Reproduced with permission from
Squara [4].Monitoring of cardiac output and mixed venous oxygen
saturation
Other studies suggest that sequential DO2 and VO2
calculations can be advantageously replaced by continuous
measurement of CO [41], SvO2 [42], or central venous oxygen
saturation [43]. The use of these variables avoids com-
pounding of measurement errors and allows for continuous
comparison between measured values and targeted values.
However, targeting a pre-established value for DO2, CO, or
SvO2 does not prove that these values meet the needs of an
individual patient [16]. These pre-established targets are
derived from normal findings or from survivors in selected
populations of patients [44,45]. Determination of the needed
value of one given variable must take into consideration the
limitation in other variables that are specific to the patient, his
past history, the actual pathologic event, the delay before
onset of shock and often recent therapeutic interventions
(Figure 3). Intuitive evaluation of the needed value of each
variable in each specific case requires considerable
expertise. Misinterpretation of information derived from PAC
placement and heterogeneity in the medical decision process
is frequent [30,31]. Even for experts, intuitive evaluation of
needs may be subject to errors [16]. In some conditions,
such as coronary disease, efforts to increase CO in order to
‘normalize’ the cardiac index to more than 2.5 l/min per m2 or
the SvO2 value to more than 70% can be harmful (see
examples given below). In addition, there is some evidence
that an excessive oxygen supply may be deleterious, either via
the useless metabolic cost of an excessive increase in DO2 or
via activation of nonoxidative systems. Failure to consider
these latter two mechanisms may also account for the poor
results obtained in controlled studies targeting nonspecific
‘supranormal’ values of DO2 [30,31]. Thus, treatment efforts
should be limited to what is necessary – no less and no more.
The relationship between cardiac output and mixed
venous oxygen saturation
All haemodynamic variables are interrelated, and ensuring
that VO2 meets needs is the best tool to ensure that global
haemodynamic status is adequate. VO2, whether calculated
by spirometry, indirect calorimetry, or using a PAC, is similar
to the plateau of VO2 in the VO2/DO2 relationship. No other
relationship between two variables allows a clear identifica-
tion of a plateau or a clear inflection point between anaero-
biosis and aerobiosis. The shape of the CO/SvO2 relationship
or the CO/EO2 relationship is bi-curvilinear and similar to the
DO2/EO2 relationship shown in Figure 1. A clear inflexion
point between aerobiosis and anaerobiosis is much more
difficult to identify than the VO2/DO2.
Critical Care    Vol 10 Suppl 3 Caille and Squara
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Figure 2
Comparison between the VO2/DO2 relationship and the VO2/time
relationship in one hypothetical example. For this figure, DO2 increased
linearly with time. This helps to identify the critical VO2 point and
eliminates the possible effect of mathematical coupling of error. DO2,
oxygen delivery; VO2, oxygen consumption. Reproduced with
permission from Squara [4].
Figure 3
Nomogram showing CI, SvO2 and VO2 isopleths (dotted black lines).
The green point shows the expected values for a 59-year-old woman at
basal metabolism, and the green dotted arrow indicates the expected
normal variations in case of hypo- or hypermetabolism. The real
position of the patient in the nomogram can be continuously
monitored. This is adequate for diagnostic purposes. The patient’s
position can move from the normal profile to a characterized area of
septic or cardiogenic shock (grey dotted arrows and areas). However,
for therapeutic objectives, this nomogram gives no idea of needs. If we
made the hypothesis that the nVO2 (red isopleth) is higher than the
oVO2, then the red double arrow indicates the difference between nVO2
and oVO2. Units for CI are l/min per m2 and for VO2 they are ml/min per
m2. CI, cardiac index; (n/o)VO2, (needed/observed) oxygen
consumption; SvO2, mixed venous oxygen saturation.Clinical examples
Example 1
Patient 1, receiving sedative drugs and mechanical ventilation,
was admitted to an ICU immediately after an aortic valve
replacement. He was hypothermic, with marbled and cold
extremities. Haemodynamic variables are listed in Table 1. In
this patient, cold extremities may be due to hypothermia, and
the supranormal serum lactate may result from postoperative
washout. Therefore, clinical evaluation including lactate level
is not relevant in evaluating macrocirculatory performance
relative to metabolic needs. Other means to explore the
balance between VO2 and needs are conflicting. The SvO2
(65%) was below the expected value and may be considered
a marker of unacceptably low CO and oxygen flow [45,46]. In
contrast the calculated oVO2 (88 ml/min per m2) is close to
expected nVO2 (90 ml/min per m2) when assessed using the
basal VO2 value for this 82-year-old man (119 ml/min per m2,
as indicated by age-specific and sex-specific normative data),
corrected according to the low body temperature. It would be
difficult to exploit the VO2/DO2 relationship. No VO2 plateau is
expected in the early postoperative period because of
increasing metabolic needs.
The clinician on duty disregards the SvO2 threshold and
concluded that the haemodynamic status was adequate to
the patient’s needs and no specific treatment was given. Two
hours later (Table 1), a decrease in lactate serum value,
normalization in SvO2 and a calculated oVO2 = basal VO2
demonstrate that metabolic needs were probably covered.
In this case, a rough interpretation of SvO2 below 70% as an
indicator of insufficient CO as compared with needs would
have led to an unjustified increase in CO. An SvO2 below
70% can be normal in elderly patients, especially if haemo-
globin level is low, as is frequently observed postoperatively.
Example 2
Patient 2, requiring sedation and mechanical ventilation, was
admitted to an ICU with a history of sudden shock and
hyperkinetic state (Table 1). Was VO2 adequate to needs?
There is agreement between the clinical signs of shock with
elevated lactate level and a calculated oVO2 below the
needed value (216 ml/min per m2) according to basal VO2 for
a 24-year-old man (152 ml/min per m2) corrected for the high
temperature. In contrast, the SvO2 value, higher than normal
values, suggests that CO and oxygen flow are adequate.
Once again, the clinician on duty disregards the SvO2
threshold and concluded that the haemodynamic status was
inadequate for the patient’s needs. A resuscitation regimen
combining cooling, fluid optimization, and dobutamine and
noradrenaline (norepinephrine) was instituted in addition to
antibiotics. CO increased, SvO2 remained stable (Table 1)
and calculated oVO2 increased over its needed value,
whereas lactate serum decreased, suggesting that metabolic
needs were covered.
In this case, an interpretation of the SvO2 above 70% as an
indicator that the hyperkinetic state was adequate to needs
would have led to insufficient resuscitation. SvO2 can be
above 70% in pathological states, for instance involving
severe impairment in tissue oxygen diffusion.
Practical implications
The rationale for incorporating the VO2/DO2 relationship into
clinical management strategies is supported by several
studies in which most of the limiting factors listed above were
avoided [13,14]. In contrast, the chances of survival are very
small in patients whose DO2 and VO2 fail to increase with
treatment, despite evidence of an oxygen deficit [13,14].
Thus, reaching the critical DO2 and ensuring that VO2 needs
Available online http://ccforum.com/content/10/S3/S4
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Table 1
Clinical parameters of two patients admitted to the ICU (sedative infusions and mechanical ventilation required)
Patient 1 (male, 84 years) Patient 2 (male, 24 years)
Parameters H0 H2 H0 H5 H6
Temperature (°C) 35.2 36.8 40.2 38.5 38.5
MAP (mmHg) 65 68 55 99 97
Heart rate (beats/min) 65 74 117 113 111
SpO2 (%) 100 100 97 96 97
Haemoglobin (g/l) 11.0 11.1 13.6 13.0 13.0
Serum lactate (mEq/l) 3 2 10.3 6.6 6.2
Cardiac index (l/min per m2) 2.1 2.3 4.1 6.5 6.4
SvO2 (%) 65 68 75 76 75
oVO2 (mL/min per m2) 88 119 178 240 237
H, delay in hours; ICU, intensive care unit; MAP, mean arterial pressure; SvO2, mixed venous oxygen saturation; oVO2, observed oxygen
consumption.are met are crucial objectives, even though these two
variables are calculated or intuitively estimated. To increase
the likelihood of identifying clinical benefits related to bedside
VO2 guided therapy, we suggest a number of practical
guidelines. As stated above, computer assistance may be
helpful in harmonizing the diagnostic reasoning processes of
different clinicians for different patients [2,35].
Early detection of shock states
Shock responds better to haemodynamic resuscitation in the
early stages [43]. Although the final objective is to provide
sufficient oxygen to each cell, there is some evidence that
rapidly achieving a sufficient total body VO2 is a prerequisite.
Late-stage shock is a far more complex situation that involves
not only the macrocirculation and microcirculation but also cell
metabolism and the consequences of cell necrosis, which
cannot be corrected by haemodynamic resuscitation alone.
Matching oxygen consumption to needs is the first
objective
In most situations, targeting a clinical improvement, a
decrease in lactate level, or a pre-established value for CO or
SvO2, or both, is an acceptable and intuitive means of
achieving adequate VO2. In complex situations, by plotting
VO2/DO2 over time during a DO2 challenge, the critical DO2
value can be evaluated rapidly by identifying the inflection
point on the curve, and resuscitation efforts can then be
limited to what is necessary. Because the critical DO2 value
can be determined visually with a 95% confidence interval of
20%, it is reasonable to limit DO2 to its observed critical value
+20%. When lactate remains high despite evidence that a
VO2 plateau has been reached, increasing DO2 further does
not seem to add benefit [13,14]. Continuous efforts to
decrease oxygen demand and to improve the microcirculation
may be more appropriate [47]. Combined analysis of the
VO2/DO2 and VO2/time relationships provides the most useful
approach, because the effects of mathematical coupling of
errors and the theoretical limitations resulting from DO2
variability in the regression line derivations are minimized. A
mild up-sloping of the VO2 plateau (slope <10%) should not
be confused with oxygen dependency. When necessary, the
critical DO2 point can be determined more accurately using
the method developed by John-Alder and coworkers [48].
To reach this objective, the best compromise must be
identified, mostly based on metabolic cost
Hyperthermia, acute respiratory failure and/or pain all
increase VO2 needs sharply. In contrast, cooling, sedation
and mechanical ventilation often produce a 50% decrease in
VO2 needs. The latter has exactly the same favourable effect
as doubling the CO or doubling the EO2. Improving EO2 must
be always considered, although this rarely produces a rapid
increase in VO2. Treating infection, excessive sedation, or
excessive water retention, for example, may increase EO2
[43]. When the only possibility is to increase DO2, clinicians
must choose among various agents that presumably differ in
their caloric effects. Arterial vasodilatation improves DO2 and
decreases myocardial oxygen requirements. In contrast,
inotropic agents and vasoconstrictors have major caloric
effects. Whatever the method used, a metabolic price must
be paid for improving VO2 and DO2 up to critical values. This
metabolic price (a part of VO2 needs) must also be limited to
what is strictly necessary.
Conclusion
Matching the VO2 and nVO2 is a crucial objective in critically ill
patients, and must take into account the specific situation of
the patient and its pathological limitations. Achieving this
objective requires one to decrease oxygen needs first, to
improve EO2 when possible and then to improve DO2. In most
situations, targeting a clinical improvement, a decrease in
lactate level, or a pre-established value for CO, SaO2, or
SvO2 (or all of these) is an acceptable and intuitive means of
achieving an adequate VO2. However, intuitive evaluation of
the needed value for each variable in each specific case
requires considerable expertise, considering all available
variables, and may be subject to error.
In complex situations, by plotting VO2/DO2 over time during a
DO2 challenge, the critical DO2 value can be rapidly identified
as the inflection point on the curve, and resuscitation efforts
can then be limited to what is necessary. Whatever the
method used, a metabolic price must be paid for improving
VO2 and DO2 to the critical values, and must be limited to
what is strictly necessary. Thus, the more complex the
critically ill presentation, the greater the number of global
haemodynamic variables that are needed.
Flow monitoring is of major interest in terms of stabilizing the
macrocirculation. A stabilized macrocirculation is a global
pre-requisite, and must be achieved before one looks at the
local microcirculation.
Although we do not have direct evidence of any
clinical benefits from invasive hemodynamic
monitoring, we believe that more intensive monitoring
(invasive or non-invasive) is needed to ensure the
safety of acutely ill patients, otherwise we would not
have ICUs.
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